
  
    
      
        Introduction_NNP
        The_DT association_NN between_IN smoking_NN and_CC rheumatoid_NN arthritis_NN
        (_( RA_NNP )_) has_VBZ been_VBN widely_RB reported_VBN [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD 10_CD 11_CD 12_CD
        13_CD 14_CD 15_CD 16_CD 17_CD 18_CD 19_CD 20_CD 21_CD ]_NN and_CC was_VBD recently_RB reviewed_VBN [_NN 20_CD
        ]_NN ._. The_DT specific_JJ association_NN between_IN smoking_NN and_CC rheumatoid_NN
        factor_NN (_( RF_NNP )_) -_: positive_JJ RA_NNP is_VBZ well_RB known_VBN and_CC meets_VBZ the_DT
        Bradford_NNP Hill_NNP criteria_NNS for_IN causation_NN [_NN 22_CD ]_NN ,_, namely_RB
        strength_NN ,_, consistency_NN ,_, plausibility_NN ,_, experimental_JJ evidence_NN ,_,
        coherence_NN ,_, temporality_NN ,_, and_CC biologic_JJ gradient_NN of_IN
        association_NN [_NN 1_CD 7_CD 8_CD 16_CD 17_CD 20_CD ]_NN ._.
        The_DT term_NN '_'' interaction_NN '_'' refers_VBZ to_TO a_DT conditional_JJ
        relationship_NN between_IN an_DT independent_JJ variable_JJ and_CC the_DT
        dependent_JJ variable_NN ._. An_DT interaction_NN exists_VBZ when_WRB the_DT
        relationship_NN between_IN an_DT independent_JJ variable_JJ 
        x_SYM and_CC an_DT outcome_NN variable_JJ 
        y_NN varies_VBZ according_VBG to_TO the_DT value_NN of_IN
        another_DT covariate_NN 
        z_SYM ._. The_DT presence_NN of_IN a_DT statistically_RB
        significant_JJ interaction_NN would_MD suggest_VB the_DT presence_NN of_IN an_DT
        underlying_VBG biologic_JJ effect_NN modification_NN and_CC provide_VB
        epidemiologic_JJ clues_NNS to_TO the_DT etiology_NN and_CC pathogenesis_NNS [_NN 23_CD ]_NN
        ._.
        Among_IN women_NNS ,_, hormonal_NN risk_NN factors_NNS for_IN RA_NNP include_VBP age_NN at_IN
        menarche_NN ,_, progestin_NN use_NN [_NN 24_CD ]_NN ,_, oral_JJ contraceptive_JJ use_NN [_NN
        25_CD ]_NN ,_, termination_NN of_IN pregnancy_NN [_NN 26_CD ]_NN ,_, lactation_NN [_NN 27_CD ]_NN ,_,
        and_CC short_JJ fertile_JJ period_NN [_NN 28_CD ]_NN ._. Epidemiologic_NNP studies_NNS do_VBP
        not_RB consistently_RB show_VB that_DT smoking_NN confers_VBZ an_DT increased_VBN
        risk_NN among_IN women_NNS ._. Indeed_RB ,_, even_RB a_DT protective_JJ effect_NN of_IN
        smoking_NN on_IN risk_NN for_IN developing_VBG RA_NNP has_VBZ been_VBN described_VBN among_IN
        women_NNS [_NN 29_CD ]_NN ._. The_DT smoking-_NN RA_NNP risk_NN is_VBZ more_RBR consistent_JJ
        across_IN studies_NNS on_IN men_NNS ._. Thus_RB ,_, the_DT risk_NN for_IN RA_NNP conferred_VBD by_IN
        smoking_VBG depends_VBZ on_IN the_DT sex_NN of_IN the_DT patient_NN ._. If_IN reports_NNS of_IN
        this_DT interaction_NN effect_NN were_VBD confirmed_VBN [_NN 1_CD ]_NN ,_, then_RB this_DT
        would_MD suggest_VB the_DT presence_NN of_IN an_DT underlying_VBG sex-specific_JJ
        factor_NN that_WDT modifies_VBZ the_DT association_NN between_IN smoking_NN and_CC
        RA_NNP ._. Therefore_RB ,_, we_PRP conducted_VBD a_DT population-based_JJ case-control_JJ
        study_NN ,_, including_VBG 1095_CD patients_NNS with_IN RA_NNP identified_VBD in_IN the_DT
        Central_NNP Finland_NNP RA_NNP Database_NNP and_CC 1530_CD control_NN individuals_NNS
        living_VBG in_IN the_DT same_JJ district_NN ._.
      
      
        Patients_NNS and_CC method_NN
        
          Cases_NNS and_CC controls_NNS
          Cases_NNS were_VBD patients_NNS drawn_VBN from_IN the_DT Central_NNP Finland_NNP RA_NNP
          Database_NNP ,_, located_VBN at_IN the_DT Jyväskylä_NNP Central_NNP Hospital_NNP ,_,
          which_WDT is_VBZ the_DT only_JJ rheumatology_NN center_NN in_IN the_DT Central_NNP
          District_NNP of_IN Finland_NNP (_( population_NN 263_CD 869_CD in_IN 2000_CD )_) ._. All_DT
          patients_NNS were_VBD diagnosed_VBN to_TO have_VB RA_NNP by_IN their_PRP$ physician_NN ._.
          The_DT Central_NNP Finland_NNP RA_NNP Database_NNP includes_VBZ demographic_JJ
          measures_NNS ,_, treatments_NNS ,_, and_CC outcomes_NNS of_IN all_DT patients_NNS with_IN
          RA_NNP seen_VBN in_IN the_DT clinic_NN since_IN January_NNP 1993_CD ._. As_IN of_IN June_NNP
          2000_CD ,_, the_DT database_NN contained_VBD information_NN on_IN 1763_CD RA_NNP
          patients_NNS ,_, 1495_CD of_IN whom_WP were_VBD still_RB alive_JJ ._. The_DT control_NN
          group_NN was_VBD a_DT random_JJ sample_NN drawn_VBN from_IN the_DT general_JJ
          population_NN ._. To_TO obtain_VB a_DT population_NN sample_NN ,_, the_DT names_NNS and_CC
          addresses_NNS of_IN 2000_CD people_NNS living_VBG in_IN the_DT Central_NNP District_NNP
          of_IN Finland_NNP were_VBD obtained_VBN from_IN the_DT organization_NN Statistics_NNPS
          of_IN Finland_NNP (_( with_IN the_DT permission_NN from_IN the_DT Ministry_NNP of_IN
          Social_NNP Affairs_NNPS and_CC Health_NNP ,_, Finland_NNP )_) ._. Statistics_NNS of_IN
          Finland_NNP obtains_NNS the_DT majority_NN of_IN its_PRP$ data_NNS from_IN diverse_JJ
          administrative_JJ registers_NNS ,_, and_CC produces_VBZ two-thirds_NNS of_IN all_DT
          Government_NNP statistics_NNS in_IN Finland_NNP http_NN :_: /_NN /_NN www_NN ._. stat_NN ._. fi_NN ._. The_DT
          Ethics_NNP Committee_NNP of_IN Jyväskylä_NNP Central_NNP Hospital_NNP approved_VBD
          the_DT study_NN ._.
        
        
          Data_NNP collection_NN
          A_DT questionnaire_NN was_VBD mailed_VBN to_TO 1495_CD candidate_NN patients_NNS
          with_IN RA_NNP and_CC to_TO 2000_CD candidate_NN control_NN individuals_NNS in_IN June_NNP
          2000_CD ._. A_DT reminder_NN letter_NN was_VBD sent_VBN 8_CD weeks_NNS later_RB to_TO
          non-responders_JJ ._. The_DT response_NN rate_NN for_IN questionnaires_NNS
          among_IN candidate_NN patients_NNS was_VBD 73_CD %_NN (_( 
          n_NN =_SYM 1095_CD )_) and_CC that_IN among_IN candidate_NN
          control_NN individuals_NNS was_VBD 77_CD %_NN (_( 1530_CD )_) ._. Functional_NNP status_NN in_IN
          activities_NNS of_IN daily_JJ living_NN was_VBD measured_VBN using_VBG the_DT Finnish_JJ
          version_NN of_IN the_DT Health_NNP Assessment_NNP Questionnaire_NNP (_( score_NN
          range_NN 0_CD -_: 3_LS )_) [_NN 30_CD ]_NN ._. Pain_NNP and_CC global_JJ status_NN were_VBD assessed_VBN
          on_IN a_DT 100_CD -_: mm_NN visual-analog_JJ scale_NN (_( range_NN 0_CD -_: 100_CD from_IN best_JJS to_TO
          worst_JJS )_) ._. Data_NNS on_IN date_NN of_IN birth_NN ,_, height_NN and_CC weight_NN ,_, sex_NN ,_,
          years_NNS of_IN education_NN ,_, and_CC current_JJ and_CC previous_JJ smoking_NN
          habits_NNS (_( never_RB /_NN ever_RB )_) were_VBD collected_VBN ._. In_IN addition_NN ,_, clinical_JJ
          features_NNS of_IN patients_NNS were_VBD obtained_VBN from_IN the_DT database_NN ._.
          Seropositivity_NNP for_IN RF_NNP (_( Ig-_NNP M_NNP )_) was_VBD defined_VBN according_VBG to_TO
          laboratory_NN references_NNS (_( >_NN 30_CD kU_NN /_NN l_NN )_) ._. One_CD of_IN us_PRP (_( TS_NNP )_)
          assessed_VBN radiographs_NNS of_IN hands_NNS and_CC feet_NNS according_VBG to_TO the_DT
          Larsen_NNP method_NN ,_, and_CC the_DT presence_NN or_CC absence_NN of_IN radiologic_JJ
          erosions_NNS was_VBD recorded_VBN as_IN a_DT dichotomous_JJ variable_NN ._.
        
        
          Statistical_NNP analysis_NN
          Data_NNP were_VBD analyzed_VBN in_IN two_CD stages_NNS ._. The_DT initial_JJ stage_NN
          was_VBD to_TO test_VB the_DT hypothesis_NNS that_IN there_EX is_VBZ a_DT primary_JJ
          interaction_NN between_IN sex_NN and_CC smoking_NN ._. This_DT was_VBD performed_VBN
          by_IN including_VBG a_DT pair-wise_JJ product_NN term_NN (_( i_NNP ._. e_SYM ._. smoking_NN ×_NN sex_NN )_)
          in_IN addition_NN to_TO the_DT individual_JJ variables_NNS in_IN a_DT logistic_JJ
          regression_NN model_NN in_IN which_WDT the_DT dependent_JJ variable_NN was_VBD case_NN
          versus_CC control_NN status_NN ._. The_DT 
          P_NN value_NN calculated_VBN for_IN the_DT
          interaction_NN term_NN in_IN the_DT logistic_JJ regression_NN model_NN was_VBD
          used_VBN to_TO determine_VB statistical_JJ significance_NN ._. If_IN this_DT
          showed_VBN the_DT presence_NN of_IN a_DT statistically_RB significant_JJ
          interaction_NN ,_, then_RB a_DT second_JJ stage_NN of_IN analyses_NNS was_VBD
          performed_VBN ._. In_IN the_DT second_JJ stage_NN ,_, parallel_JJ case-control_JJ
          analyses_NNS were_VBD performed_VBN for_IN men_NNS and_CC women_NNS using_VBG
          multivariable_JJ logistic_JJ regression_NN ._. The_DT independent_JJ
          variables_NNS in_IN these_DT models_NNS were_VBD age_NN ,_, education_NN ,_, body_NN mass_NN
          index_NN ,_, Health_NNP Assessment_NNP Questionnaire_NNP disability_NN index_NN ,_,
          self-reports_JJ of_IN pain_NN and_CC overall_JJ health_NN assessments_NNS ,_, as_RB
          well_RB as_IN a_DT smoking_NN variable_JJ ._. The_DT last_JJ five_CD covariates_NNS were_VBD
          included_VBN in_IN the_DT model_NN because_IN these_DT can_MD potentially_RB
          confound_NN the_DT smoking-_NN RA_NNP relationship_NN ._. Separate_NNP regression_NN
          analyses_NNS were_VBD performed_VBN to_TO assess_VB the_DT effect_NN of_IN both_DT the_DT
          smoking_NN variables_NNS (_( current_JJ smoking_NN and_CC past_JJ smoking_NN )_) on_IN
          the_DT risk_NN for_IN RA_NNP ._. Forward_NNP or_CC backward_RB stepwise_NN selections_NNS
          were_VBD not_RB used_VBN ,_, and_CC all_DT clinically_RB important_JJ covariates_NNS
          were_VBD included_VBN in_IN the_DT multivariable_JJ models_NNS ._. We_PRP performed_VBD
          Student_NNP 's_POS 
          t_NN -_: test_NN to_TO compare_VB differences_NNS in_IN
          mean_NN values_NNS and_CC Pearson_NNP 's_POS χ_NN 2_CD test_NN to_TO compare_VB differences_NNS
          in_IN proportions_NNS ._. Analyses_NNS were_VBD performed_VBN using_VBG STATA_NNP
          ®_NN Version_NNP 7_CD ._. 0_CD software_NN (_( Stata_NNP Corporation_NNP ,_, College_NNP
          Station_NNP ,_, TX_NNP ,_, USA_NNP )_) ._.
        
      
      
        Results_NNS
        The_DT mean_JJ age_NN of_IN the_DT patients_NNS was_VBD 62_CD years_NNS (_( range_NN 19_CD -_: 96_CD
        years_NNS )_) and_CC 71_CD %_NN were_VBD female_JJ ;_: the_DT mean_JJ age_NN of_IN control_NN
        individuals_NNS was_VBD 55_CD years_NNS (_( range_NN 30_CD -_: 91_CD years_NNS )_) and_CC 72_CD %_NN were_VBD
        female_JJ ._. Among_IN RA_NNP patients_NNS ,_, the_DT mean_JJ disease_NN duration_NN was_VBD
        11_CD ._. 3_LS years_NNS (_( range_NN 0_CD ._. 2_CD -_: 47_CD years_NNS )_) ,_, 68_CD ._. 6_CD %_NN were_VBD RF-positive_NNP ,_,
        and_CC 60_CD %_NN had_VBD erosions_NNS in_IN their_PRP$ hand_NN or_CC feet_NNS radiographs_NNS ._.
        There_EX were_VBD no_DT statistically_RB significant_JJ differences_NNS in_IN the_DT
        proportion_NN of_IN seropositivity_NN for_IN RF_NNP (_( 67_CD %_NN versus_CC 71_CD %_NN ;_: 
        P_NN =_SYM 0_CD ._. 29_CD )_) ,_, frequency_NN of_IN erosive_JJ
        disease_NN (_( 59_CD %_NN versus_CC 60_CD ._. 3_LS %_NN ;_: 
        P_NN =_SYM 0_CD ._. 84_CD )_) ,_, or_CC disease_NN duration_NN (_( 11_CD ._. 7_CD
        years_NNS versus_CC 10_CD ._. 5_LS years_NNS ;_: 
        P_NN =_SYM 0_CD ._. 06_CD )_) between_IN men_NNS and_CC women_NNS with_IN
        RA_NNP ._.
        In_IN preliminary_JJ logistic_JJ regression_NN analyses_NNS in_IN which_WDT any_DT
        RA_NNP was_VBD the_DT dependent_JJ variable_NN of_IN interest_NN ,_, sex_NN exhibited_VBN a_DT
        statistically_RB significant_JJ interaction_NN with_IN current_JJ /_NN past_JJ
        smoking_NN (_( all_DT 
        P_NN <_NN 0_CD ._. 001_CD )_) ._. Among_IN women_NNS there_RB was_VBD
        significant_JJ interaction_NN between_IN age_NN and_CC past_JJ smoking_NN (_( 
        P_NN =_SYM 0_CD ._. 01_CD )_) but_CC not_RB with_IN current_JJ
        smoking_NN (_( 
        P_NN =_SYM 0_CD ._. 13_CD )_) ._. Among_IN men_NNS there_EX were_VBD no_DT
        statistically_RB significant_JJ interactions_NNS between_IN age_NN and_CC
        current_JJ smoking_NN (_( 
        P_NN =_SYM 0_CD ._. 12_CD )_) and_CC age_NN and_CC past_JJ smoking_NN (_( 
        P_NN =_SYM 0_CD ._. 97_CD )_) ._. Subsequent_JJ analyses_NNS were_VBD
        performed_VBN separately_RB for_IN men_NNS and_CC women_NNS ._.
        Table_NNP 1_CD shows_VBZ comparisons_NNS between_IN patients_NNS and_CC control_NN
        individuals_NNS by_IN sex_NN ._. Among_IN both_DT sexes_NNS ,_, patients_NNS were_VBD older_JJR ,_,
        less_RBR well_RB educated_VBN ,_, more_RBR disabled_JJ ,_, and_CC reported_VBD poorer_RBR
        general_JJ health_NN and_CC increased_VBN functional_JJ disability_NN and_CC pain_NN
        in_IN comparison_NN with_IN control_NN individuals_NNS ._. Female_NNP patients_NNS
        were_VBD less_RBR likely_JJ to_TO report_VB past_JJ or_CC current_JJ smoking_NN than_IN
        were_VBD female_JJ control_NN individuals_NNS ._. Among_IN men_NNS ,_, there_EX was_VBD no_DT
        statistically_RB significant_JJ difference_NN in_IN the_DT proportion_NN of_IN
        current_JJ smokers_NNS between_IN patients_NNS and_CC control_NN individuals_NNS ,_,
        but_CC patients_NNS were_VBD more_RBR likely_JJ to_TO have_VB smoked_VBD in_IN the_DT past_NN
        than_IN were_VBD control_NN individuals_NNS (_( Table_NNP 1_LS )_) ._.
        In_IN the_DT multivariable_JJ models_NNS ,_, we_PRP adjusted_VBD for_IN age_NN ,_, body_NN
        mass_NN index_NN ,_, level_NN of_IN education_NN and_CC indices_NNS of_IN functional_JJ
        disability_NN ,_, pain_NN ,_, and_CC general_JJ health_NN ._. Parallel_JJ analyses_NNS
        looking_VBG at_IN the_DT effect_NN of_IN smoking_NN on_IN the_DT risk_NN of_IN RA_NNP were_VBD
        performed_VBN in_IN subgroups_NNS of_IN patients_NNS defined_VBN by_IN presence_NN or_CC
        absence_NN of_IN RF_NNP as_RB well_RB as_IN all_DT patients_NNS with_IN RA_NNP (_( Tables_NNP 2_CD and_CC
        3_LS )_) ._.
        Multivariable_NNP analyses_NNS for_IN women_NNS (_( Table_NNP 2_LS )_) showed_VBD that_IN
        there_EX was_VBD no_DT significant_JJ association_NN between_IN current_JJ or_CC
        past_JJ smoking_NN and_CC RF-positive_NNP or_CC RF-negative_NNP RA_NNP ._. Although_IN
        not_RB statistically_RB significant_JJ ,_, the_DT magnitude_NN of_IN risk_NN was_VBD
        consistently_RB less_JJR than_IN 1_CD ._. 0_CD in_IN both_DT RF-positive_NNP and_CC
        RF-negative_NNP patients_NNS with_IN RA_NNP ._.
        For_IN men_NNS (_( Table_NNP 3_LS )_) ,_, past_JJ smoking_NN was_VBD consistently_RB
        associated_VBN with_IN RF-positive_NNP RA_NNP (_( odds_NNS ratio_NN 2_CD ._. 3_CD ,_, 95_CD %_NN
        confidence_NN interval_NN 1_CD ._. 3_CD -_: 3_CD ._. 9_CD )_) ._. Neither_DT current_JJ nor_CC past_JJ
        smoking_NN was_VBD associated_VBN with_IN RF-negative_NNP RA_NNP ._. Overall_RB ,_, past_JJ
        smoking_NN (_( odds_NNS ratio_NN 2_CD ._. 0_CD ,_, 95_CD %_NN confidence_NN interval_NN 1_CD ._. 2_CD -_: 3_CD ._. 2_LS )_)
        but_CC not_RB current_JJ smoking_NN (_( odds_NNS ratio_NN 1_CD ._. 2_CD ,_, 95_CD %_NN confidence_NN
        interval_NN 0_CD ._. 7_CD -_: 2_CD ._. 0_CD )_) was_VBD associated_VBN with_IN increased_VBN risk_NN for_IN
        RA_NNP ._.
      
      
        Discussion_NNP
        In_IN the_DT present_JJ study_NN we_PRP confirmed_VBD the_DT earlier_JJR
        observation_NN that_DT smoking_NN is_VBZ a_DT risk_NN factor_NN for_IN RA_NNP in_IN men_NNS but_CC
        not_RB in_IN women_NNS [_NN 1_CD 17_CD ]_NN ._. In_IN addition_NN ,_, we_PRP statistically_RB
        tested_VBD and_CC confirmed_VBN the_DT interaction_NN between_IN smoking_NN and_CC
        sex_NN ,_, thereby_RB providing_VBG evidence_NN in_IN support_NN of_IN a_DT biologic_JJ
        interaction_NN between_IN smoking_NN and_CC RA_NNP ._.
        Smoking_NN is_VBZ known_VBN to_TO be_VB associated_VBN with_IN production_NN of_IN RF_NNP
        [_NN 6_CD 16_CD 20_CD ]_NN ;_: RF_NNP production_NN ,_, in_IN turn_NN ,_, often_RB precedes_VBZ the_DT
        development_NN of_IN clinical_JJ disease_NN [_NN 12_CD 16_CD ]_NN ._. Furthermore_RB ,_, it_PRP
        appears_VBZ to_TO be_VB independent_JJ of_IN HLA-DR_NNP restricted_VBD immune_JJ
        response_NN [_NN 13_CD ]_NN ._. In_IN our_PRP$ study_NN ,_, we_PRP found_VBD that_IN this_DT paradigm_NN
        held_VBN well_RB for_IN men_NNS but_CC not_RB women_NNS ._. Why_WRB could_MD it_PRP be_VB ?_. One_CD of_IN
        the_DT explanations_NNS for_IN this_DT could_MD be_VB that_IN the_DT immunologic_JJ
        cascade_NN triggered_VBN by_IN smoking_VBG and_CC leading_VBG to_TO RF_NNP production_NN
        and_CC subsequently_RB to_TO clinical_JJ RA_NNP is_VBZ modulated_JJ differently_RB in_IN
        men_NNS and_CC in_IN women_NNS ._. The_DT most_RBS obvious_JJ biologic_JJ difference_NN
        between_IN men_NNS and_CC women_NNS is_VBZ the_DT hormonal_NN milieu_NN ,_, although_IN
        other_JJ sex-specific_JJ factors_NNS cannot_NN be_VB ruled_VBN out_RP ._. In_IN our_PRP$
        analyses_NNS we_PRP found_VBD a_DT significant_JJ age-smoking_JJ interaction_NN
        among_IN women_NNS -_: an_DT observation_NN that_WDT is_VBZ not_RB inconsistent_JJ with_IN
        this_DT hypothesis_NNS ._.
        Although_IN we_PRP were_VBD not_RB able_JJ to_TO test_VB this_DT hypothesis_NNS
        directly_RB in_IN our_PRP$ data_NNS (_( because_IN the_DT relevant_JJ reproductive_JJ
        variables_NNS were_VBD not_RB available_JJ )_) ,_, a_DT review_NN of_IN the_DT literature_NN
        gives_VBZ some_DT clues_NNS ._. In_IN studies_NNS conducted_VBN in_IN women-only_JJ
        cohorts_NNS ,_, the_DT presence_NN of_IN association_NN between_IN smoking_NN and_CC RA_NNP
        appeared_VBD to_TO be_VB dependent_JJ on_IN menopausal_NN status_NN of_IN study_NN
        participants_NNS ._. In_IN a_DT population-based_JJ study_NN conducted_VBN in_IN
        Iowa_NNP ,_, USA_NNP ,_, which_WDT examined_VBD postmenopausal_NN women_NNS only_RB ,_, a_DT
        dose-dependent_JJ effect_NN of_IN smoking_NN was_VBD evident_JJ (_( relative_JJ risk_NN
        for_IN RA_NNP for_IN current_JJ smokers_NNS versus_CC never_RB smokers_NNS 2_CD ._. 0_CD )_) [_NN 11_CD ]_NN
        ._. On_IN the_DT other_JJ hand_NN ,_, data_NNS from_IN the_DT prospective_JJ Nurses_NNP
        Health_NNP Study_NNP [_NN 2_CD ]_NN ,_, which_WDT examined_VBD all_DT (_( primarily_RB
        menstruating_VBG )_) women_NNS aged_VBN 30_CD -_: 55_CD years_NNS ,_, did_VBD not_RB show_VB a_DT
        statistically_RB significant_JJ relationship_NN between_IN current_JJ or_CC
        past_JJ smoking_NN and_CC RA_NNP ._. Furthermore_RB ,_, in_IN the_DT Women_NNP 's_POS Health_NNP
        Cohort_NNP Study_NNP [_NN 7_CD ]_NN ,_, the_DT effect_NN size_NN of_IN smoking_NN was_VBD
        relatively_RB modest_JJ (_( relative_JJ risk_NN 1_CD ._. 39_CD and_CC 1_CD ._. 49_CD for_IN all_DT RA_NNP
        and_CC RF-positive_NNP RA_NNP ,_, respectively_RB )_) as_IN compared_VBN with_IN that_DT in_IN
        the_DT Iowa_NNP study_NN ._. Interpreting_NNP our_PRP$ findings_NNS of_IN an_DT interaction_NN
        between_IN smoking_NN and_CC sex_NN in_IN the_DT light_NN of_IN published_VBN data_NNS ,_, we_PRP
        propose_VBP that_IN being_VBG a_DT menstruating_VBG woman_NN acts_NNS as_IN a_DT biologic_JJ
        effect_NN modifier_NN that_IN blocks_VBZ the_DT smoking-_NN RF-RA_NNP pathway_NN ._. We_PRP
        did_VBD not_RB have_VB the_DT information_NN on_IN menopausal_NN status_NN to_TO test_VB
        this_DT hypothesis_NNS directly_RB ._. Instead_RB ,_, we_PRP conducted_VBD multiple_JJ
        pair-wise_JJ interaction_NN tests_NNS between_IN age_NN and_CC smoking_NN for_IN men_NNS
        and_CC women_NNS separately_RB ._. Interestingly_RB ,_, we_PRP found_VBD that_IN there_EX
        was_VBD a_DT significant_JJ age-smoking_JJ interaction_NN among_IN women_NNS but_CC
        not_RB among_IN men_NNS ._. This_DT smoking-sex_JJ effect_NN modification_NN
        paradigm_NN we_PRP propose_VBP not_RB only_RB might_MD explain_VB a_DT lack_NN of_IN
        increased_VBN risk_NN for_IN RA_NNP among_IN women_NNS smokers_NNS ,_, but_CC also_RB
        provides_VBZ a_DT theoretical_JJ basis_NN for_IN the_DT observation_NN that_DT
        smoking_NN reduces_VBZ the_DT risk_NN for_IN RA_NNP in_IN women_NNS [_NN 29_CD ]_NN ._.
        There_EX are_VBP several_JJ areas_NNS of_IN substantial_JJ strength_NN in_IN the_DT
        present_JJ study_NN ._. First_LS ,_, the_DT study_NN participants_NNS were_VBD drawn_VBN
        from_IN a_DT population-based_JJ register_NN of_IN RA_NNP patients_NNS (_( i_NNP ._. e_SYM ._. a_DT
        rheumatology_NN clinic_NN in_IN which_WDT all_DT patients_NNS with_IN RA_NNP living_VBG in_IN
        the_DT particular_JJ referral_NN area_NN are_VBP followed_VBN )_) and_CC the_DT control_NN
        individuals_NNS were_VBD drawn_VBN from_IN the_DT same_JJ ,_, geographically_RB
        well-defined_JJ general_JJ population_NN ._. Second_JJ ,_, the_DT participation_NN
        rates_NNS for_IN patients_NNS and_CC control_NN individuals_NNS were_VBD good_JJ ._.
        Validated_NNP diagnoses_NNS and_CC exposures_NNS were_VBD used_VBN ._. The_DT smoking_NN
        histories_NNS were_VBD also_RB validated_JJ using_VBG hospital_NN medical_JJ
        records_NNS ,_, by_IN comparing_VBG the_DT questionnaire_NN response_NN with_IN the_DT
        information_NN from_IN the_DT standard_JJ clinical_JJ history_NN and_CC physical_JJ
        examination_NN ._. Finally_RB ,_, the_DT numerical_JJ strength_NN of_IN this_DT study_NN
        provided_VBD sufficient_JJ statistical_JJ power_NN to_TO quantitate_NN the_DT
        risk_NN of_IN smoking_NN on_IN RF-positive_NNP and_CC RF-negative_NNP RA_NNP
        separately_RB ._.
        The_DT potential_JJ limitations_NNS of_IN the_DT study_NN also_RB must_MD be_VB
        addressed_VBN ._. By_IN design_NN ,_, the_DT study_NN was_VBD an_DT unmatched_JJ
        case-control_JJ study_NN ._. The_DT control_NN individuals_NNS were_VBD younger_JJR
        than_IN the_DT cases_NNS ._. Many_JJ control_NN individuals_NNS were_VBD younger_JJR than_IN
        50_CD years_NNS ._. This_DT may_MD lead_VB to_TO arguments_NNS that_WDT control_NN
        individuals_NNS were_VBD not_RB old_JJ enough_RB to_TO have_VB developed_VBN RA_NNP and_CC
        that_IN an_DT age-matched_JJ design_NN would_MD have_VB been_VBN more_RBR
        appropriate_JJ ._. However_RB ,_, such_JJ a_DT bias_NN does_VBZ not_RB explain_VB our_PRP$
        observations_NNS as_IN the_DT age_NN differential_NN was_VBD found_VBN in_IN both_DT men_NNS
        and_CC women_NNS ._. In_IN addition_NN to_TO performing_VBG tests_NNS of_IN interaction_NN
        between_IN age_NN and_CC smoking_NN ,_, we_PRP adjusted_VBD for_IN the_DT effect_NN of_IN age_NN
        in_IN multivariable_JJ models_NNS ._. To_TO address_VB the_DT concern_NN that_IN
        successive_JJ birth_NN cohorts_NNS are_VBP associated_VBN with_IN lower_JJR
        prevalence_NN rates_NNS of_IN smoking_NN and_CC leading_VBG to_TO bias_NN in_IN our_PRP$
        findings_NNS ,_, analyses_NNS were_VBD repeated_VBN ,_, adjusting_VBG for_IN the_DT effect_NN
        of_IN calendar_NN year_NN of_IN birth_NN ._. We_PRP found_VBD that_IN the_DT results_NNS were_VBD
        essentially_RB the_DT same_JJ ._. We_PRP believe_VBP that_IN matching_VBG by_IN age_NN would_MD
        have_VB been_VBN ,_, overall_JJ ,_, disadvantageous_JJ to_TO the_DT study_NN because_IN
        such_JJ an_DT approach_NN would_MD not_RB allow_VB us_PRP to_TO study_VB important_JJ
        interactions_NNS between_IN age_NN and_CC other_JJ covariates_NNS ._.
        Unfortunately_RB ,_, data_NNS on_IN the_DT temporal_JJ sequence_NN of_IN smoking_NN and_CC
        RA_NNP ,_, as_RB well_RB as_IN on_IN any_DT dose-response_JJ association_NN ,_, were_VBD not_RB
        available_JJ and_CC could_MD not_RB be_VB analyzed_VBN ._.
        The_DT differences_NNS in_IN the_DT risk_NN estimates_NNS for_IN current_JJ
        smoking_NN and_CC past_JJ smoking_NN may_MD appear_VB counter-intuitive_JJ ._. The_DT
        explanation_NN lies_VBZ in_IN the_DT case-control_JJ design_NN of_IN the_DT study_NN ._.
        Both_DT smoking_NN and_CC RA_NNP can_MD independently_RB increase_VB the_DT risk_NN for_IN
        mortality_NN ;_: the_DT potential_JJ patients_NNS who_WP are_VBP also_RB continuing_VBG
        smokers_NNS are_VBP more_RBR likely_JJ to_TO have_VB died_VBN than_IN are_VBP smokers_NNS in_IN
        the_DT general_JJ population_NN ,_, thus_RB never_RB entering_VBG the_DT study_NN [_NN 31_CD
        ]_NN ._. This_DT differential_NN mortality_NN could_MD have_VB resulted_VBN in_IN an_DT
        underestimation_NN of_IN the_DT association_NN between_IN current_JJ smoking_NN
        and_CC RA_NNP ._. However_RB ,_, it_PRP is_VBZ unlikely_JJ that_IN there_EX is_VBZ a_DT difference_NN
        in_IN smoking-related_JJ mortality_NN between_IN men_NNS and_CC women_NNS of_IN such_JJ
        a_DT magnitude_NN as_IN to_TO cause_VB the_DT observed_VBN sex_NN differential_NN ._.
        Another_DT equally_RB plausible_JJ explanation_NN would_MD be_VB that_IN the_DT
        diagnosis_NN of_IN RA_NNP might_MD have_VB led_VBN to_TO lifestyle_NN changes_NNS ,_,
        leading_VBG to_TO cessation_NN of_IN smoking_NN ._. However_RB ,_, there_EX is_VBZ little_JJ
        evidence_NN to_TO suggest_VB that_DT onset_NN of_IN RA_NNP would_MD affect_VB smoking_VBG
        behavior_NN in_IN men_NNS and_CC women_NNS in_IN a_DT different_JJ manner_NN (_( i_NNP ._. e_SYM ._. there_EX
        is_VBZ no_DT published_VBN literature_NN or_CC rationale_NN for_IN supposing_VBG that_IN
        men_NNS and_CC women_NNS tend_VBP to_TO take_VB up_RP or_CC quit_VBD smoking_VBG differently_RB
        when_WRB they_PRP develop_VBP RA_NNP )_) ._.
      
      
        Conclusion_NNP
        Data_NNP presented_VBD in_IN this_DT report_NN suggest_VBP that_IN factors_NNS
        related_VBN to_TO the_DT sex_NN of_IN an_DT individual_JJ modify_VB the_DT effect_NN of_IN
        smoking_NN on_IN the_DT risk_NN of_IN RA_NNP ._. Epidemiologic_NNP studies_NNS that_WDT do_VBP
        not_RB explore_VB and_CC account_VB for_IN the_DT significant_JJ smoking-sex_JJ
        interaction_NN are_VBP likely_JJ to_TO show_VB inaccurate_JJ and_CC even_RB biased_VBN
        estimates_NNS of_IN the_DT association_NN between_IN smoking_NN and_CC RA_NNP ._. Our_PRP$
        study_NN also_RB highlights_VBZ the_DT need_NN for_IN further_JJ research_NN on_IN
        smoking_NN ,_, RA_NNP ,_, and_CC ,_, in_IN addition_NN ,_, their_PRP$ effect_NN modification_NN by_IN
        sex-related_JJ factors_NNS like_IN menopause_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        RA_NNP =_SYM rheumatoid_NN arthritis_NN ;_: RF_NNP =_SYM rheumatoid_NN factor_NN ._.
      
    
  
